Clinical trial

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)1999-11-01Date precision: month

Registry last updated2012-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Leukemiaunresolved

Lymphomaunresolved

Multiple Myeloma and Plasma Cell Neoplasmunresolved

Myelodysplastic/Myeloproliferative Diseasesunresolved

Interventions

filgrastimBIOLOGICAL

recombinant flt3 ligandBIOLOGICAL

recombinant human thrombopoietinBIOLOGICAL

recombinant interleukin-3BIOLOGICAL

in vitro-treated peripheral blood stem cell transplantationPROCEDURE

Sponsors & collaborators

Northwestern Universitylead sponsor

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.